> News & Events > 2019-07-17 18:11:49 Hits: Source: Original
Updated on July 17, 2019

A gynecology team from Hospital Universitari Mútua Terrassa, Spain revisits Suining Central Hospital

On July 11, 2019, a gynecology and HIFU treatment team including Dr. Antoni Pessarodona, Dr. Jordi Rodriguez, and Dr. Núria Pons Serra from Hospital Universitari Mútua Terrassa (HUMT), Spain paid an academic exchange visit to Suining Central Hospital (SCH) upon invitation.

Up to now, HUMT has sent 5 professionals to SCH for HIFU training. Dr. Núria Pons Serra and Dr. Jordi Rodriguez trained in HIFU technology at the HIFU Center of SCH respectively in 2017 and 2018, and they have carried out relevant work in their own hospital after training. This time they revisited SCH with knotty problems and puzzles encountered in their daily work, during which they observed HIFU treatment procedures and had in-depth communication with the HIFU experts in SCH on the treatment methods of large uterine fibroids and the diagnosis and treatment of adenomyosis.

After nearly 10 years of development, 8000 cases have been treated accumulatively in the HIFU Center of SCH, during which rich clinical experience has been accumulated and the safety and effectiveness of HIFU technology have been fully validated. In order to further expand the clinical application of HIFU technology in other specialties, a multidisciplinary meeting on HIFU was held on July 11 in SCH with over 20 participants from departments of Gynecology & obstetrics, Oncology Center, Digestive Disease Center, Urology, Breast Surgery, Ultrasound ,and Orthopaedics. The visiting team from HUMT were also invited to attend the meeting. At the meeting, the experts had a lively discussion on the inclusion criteria, case selection, quality control, therapeutic effect evaluation, multi-disciplinary collaboration, and ethical issues of HIFU treatment for diseases in various specialties, which generated many constructive opinions and suggestions. The three visiting experts said that the experience gained from the HIFU treatment of benign gynecological diseases should benefit more patients; And they suggested that the technology be used for the palliative and adjuvant treatment of advanced cancer patients to improve their life quality and prognosis. The experts of the related specialties have reached a preliminary consensus at the meeting, and they plan to carry out basic research on HIFU treatment of benign diseases and to expand its application in malignant cases.